COVID-19 Outcomes and Risk Factors Among People Living with HIV

Lamontagne E. COVID-19 pandemic increases socioeconomic vulnerability of LGBTI+ communities and their susceptibility to HIV. AIDS 2020 San Francisco/Oakland 2020. July 14. abstract LBPEE53.

Centers for Disease Control and Prevention. HIV Surveillance Report, 2020; vol. 33. https://www.cdc.gov/hiv/library/reports/hiv-surveillance.html. Published May 2022. Accessed June 2 2022.

Garcia Garrido HM, Mak AMR, Wit F, et al. Incidence and risk factors for invasive pneumococcal disease and community-acquired pneumonia in human immunodeficiency virus-infected individuals in a high-income setting. Clin Infect Dis. 2020;71(1):41–50.

PubMed  Article  Google Scholar 

Sachdev D, Mara E, Hsu L, et al. COVID-19 Susceptibility and outcomes among people living with HIV in San Francisco. J Acquir Immune Defic Syndr. 2020;86(1):19–21.

•• Braunstein SL, Lazar R, Wahnich A, Daskalakis DC, Blackstock OJ. Coronavirus disease 2019 (COVID-19) infection among people with human immunodeficiency virus in New York City: a population-level analysis of linked surveillance data. Clin Infect Dis. 2020;72(12):e1021–9. Braunstein and colleagues present a methodolocially rigorous examination of the impact of HIV status on COVID-19 outcomes among PLWH in New York City. This study also demonstrated the impact of racial/ethnic and socioeconomic disparities on COVID-19 outcomes.

Article  CAS  Google Scholar 

Fitzpatrick ME, Kunisaki KM, Morris A. Pulmonary disease in HIV-infected adults in the era of antiretroviral therapy. AIDS. 2018;32(3):277–92.

PubMed  Article  Google Scholar 

Crothers K. Chronic obstructive pulmonary disease in patients who have HIV infection. Clin Chest Med. 2007;28(3):575–87, vi.

PubMed  Article  Google Scholar 

Meyerowitz EA, Kim AY, Ard KL, et al. Disproportionate burden of coronavirus disease 2019 among racial minorities and those in congregate settings among a large cohort of people with HIV. AIDS 2020; 34(12).

Mdodo R, Frazier EL, Dube SR, et al. Cigarette smoking prevalence among adults with HIV compared with the general adult population in the United States: cross-sectional surveys. Ann Intern Med. 2015;162(5):335–44.

PubMed  Article  Google Scholar 

Goldstein ND, Webster JL, Robinson LF, Welles SL. Disparities of COVID-19 and HIV occurrence based on neighborhood infection incidence in Philadelphia, Pennsylvania. Am J Public Health. 2022;112(3):408–16.

PubMed  Article  Google Scholar 

Zlot AI, Capizzi J, Bush L, Menza TW. Impact of COVID-19 Among immigrant and communities of color living with HIV in Oregon, 2020: two pandemics rooted in racism. J Immigr Minor Health. 2021;23(6):1348–53.

PubMed  PubMed Central  Article  Google Scholar 

Sheth AN, Althoff KN, Brooks JT. Influenza susceptibility, severity, and shedding in HIV-infected adults: a review of the literature. Clin Infect Dis. 2011;52(2):219–27.

PubMed  PubMed Central  Article  Google Scholar 

Triant VA. Cardiovascular disease and HIV infection. Curr HIV/AIDS Rep. 2013;10(3):199–206.

PubMed  PubMed Central  Article  Google Scholar 

Silverberg MJ, Leyden W, Hernández-Ramírez RU, et al. Timing of antiretroviral therapy initiation and risk of cancer among persons living with human immunodeficiency virus. Clin Infect Dis. 2021;72(11):1900–9.

CAS  PubMed  Article  Google Scholar 

Hernandez-Romieu AC, Garg S, Rosenberg ES, Thompson-Paul AM, Skarbinski J. Is diabetes prevalence higher among HIV-infected individuals compared with the general population? Evidence from MMP and NHANES 2009–2010. BMJ Open Diabetes Res Care. 2017;5(1):e000304.

PubMed  PubMed Central  Article  Google Scholar 

Spinelli MA, Lynch KL, Yun C, et al. SARS-CoV-2 seroprevalence, and IgG concentration and pseudovirus neutralising antibody titres after infection, compared by HIV status: a matched case-control observational study. The Lancet HIV. 2021;8(6):e334–41.

PubMed  PubMed Central  Article  Google Scholar 

Buechler MB, Newman LP, Chohan BH, Njoroge A, Wamalwa D, Farquhar C. T cell anergy and activation are associated with suboptimal humoral responses to measles revaccination in HIV-infected children on anti-retroviral therapy in Nairobi. Kenya Clin Exp Immunol. 2015;181(3):451–6.

CAS  PubMed  Article  Google Scholar 

Avelino-Silva VI, Miyaji KT, Hunt PW, et al. CD4/CD8 ratio and KT ratio predict yellow fever vaccine immunogenicity in HIV-infected patients. PLoS Negl Trop Dis. 2016;10(12):e0005219.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Colin de Verdiere N, Durier C, Samri A, et al. Immunogenicity and safety of yellow fever vaccine in HIV-1-infected patients. AIDS. 2018;32(16):2291–9.

CAS  PubMed  Article  Google Scholar 

Parmigiani A, Alcaide ML, Freguja R, et al. Impaired antibody response to influenza vaccine in HIV-infected and uninfected aging women is associated with immune activation and inflammation. PLoS One. 2013;8(11):e79816.

PubMed  PubMed Central  Article  Google Scholar 

Spinelli MA. SARS-CoV-2 vaccination in people with HIV. The Lancet HIV 2021. Epub ahead of print https://doi.org/10.1016/S2352-3018(21)00128-4.

van den Berg R, van Hoogstraten I, van Agtmael M. Non-responsiveness to hepatitis B vaccination in HIV seropositive patients; possible causes and solutions. AIDS Rev. 2009;11(3):157–64.

PubMed  Google Scholar 

Collier AC, Corey L, Murphy VL, Handsfield HH. Antibody to human immunodeficiency virus (HIV) and suboptimal response to hepatitis B vaccination. Ann Intern Med. 1988;109(2):101–5.

CAS  PubMed  Article  Google Scholar 

Pasricha N, Datta U, Chawla Y, et al. Immune responses in patients with HIV infection after vaccination with recombinant Hepatitis B virus vaccine. BMC Infect Dis. 2006;6:65.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Kroon FP, van Dissel JT, Labadie J, van Loon AM, van Furth R. Antibody response to diphtheria, tetanus, and poliomyelitis vaccines in relation to the number of CD4+ T lymphocytes in adults infected with human immunodeficiency virus. Clin Infect Dis. 1995;21(5):1197–203.

CAS  PubMed  Article  Google Scholar 

von Mollendorf C, Hellferscee O, Valley-Omar Z, et al. Influenza viral shedding in a prospective cohort of HIV-infected and uninfected children and adults in 2 provinces of South Africa, 2012–2014. J Infect Dis. 2018;218(8):1228–37.

Article  Google Scholar 

Antonelli M, Penfold RS, Merino J, et al. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study. Lancet Infect Dis. 2022;22(1):43–55.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Brown LB, Spinelli MA, Gandhi M. The interplay between HIV and COVID-19: summary of the data and responses to date. Curr Opin HIV AIDS. 2021;16(1):63–73.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Rutishauser RL, Hartogensis W, Deguit CD, et al. Early and delayed antiretroviral therapy results in comparable reductions in CD8(+) T cell exhaustion marker expression. AIDS Res Hum Retroviruses. 2017;33(7):658–67.

Fromentin R, Bakeman W, Lawani MB, et al. CD4+ T cells expressing PD-1, TIGIT and LAG-3 contribute to HIV persistence during ART. PLoS Pathog. 2016;12(7):e1005761.

PubMed  PubMed Central  Article  CAS  Google Scholar 

•• Del Amo J, Polo R, Moreno S, et al. Incidence and severity of COVID-19 in HIV-positive persons receiving antiretroviral therapy: a cohort study. Ann Intern Med 2022. This prospective cohort study among HIV clinics in 60 hospitals that serve over 75,000 PLWH in Madrid observed lower risk of SARS-CoV-2 infection among PLWH on ART compared to the general population, although the risk was similar between PLWH and the general population once health care workers were excluded.

Huang J, Xie N, Hu X, et al. Epidemiological, virological and serological features of COVID-19 cases in people living with HIV in Wuhan City: a population-based cohort study. Clin Infect Dis. 2020;73(7):e2086–e2094.

•• Tesoriero JM, Swain CE, Pierce JL, et al. COVID-19 outcomes among persons living with or without diagnosed hiv infection in New York state. JAMA Netw Open. 2021;4(2):e2037069. This study by Tesoriero and colleagues demonstrates the impact of living with HIV on COVID-19 outcomes in a large population-based sample among PLWH in New York State.

PubMed  PubMed Central  Article  Google Scholar 

Yang X, Sun J, Patel RC, et al. Associations between HIV infection and clinical spectrum of COVID-19: a population level analysis based on US National COVID Cohort Collaborative (N3C) data. Lancet HIV. 2021;8(11):e690–700.

PubMed  PubMed Central  Article  Google Scholar 

Boulle A, Davies MA, Hussey H, et al. Risk factors for COVID-19 death in a population cohort study from the Western Cape Province, South Africa. Clin Infect Dis. 2021;73(7):e2005–e2015.

Spinelli MA, Brown LB, Glidden DV, et al. SARS-CoV-2 incidence, testing rates, and severe COVID-19 outcomes among people with and without HIV. AIDS. 2021;35(15):2545–7.

Charre C, Icard V, Pradat P, et al. Coronavirus disease 2019 attack rate in HIV-infected patients and in preexposure prophylaxis users. AIDS. 2020;34(12):1765–70.

CAS  PubMed  Article  Google Scholar 

Park LR, CT Rentsch, Sigel K, Rodriguez-Barradas M, Brown ST, Goetz MB, Williams EC, Althoff K, Brau N, Aoun-Barakat L, Tseng A, Justice AC, Tate JP. COVID-19 in the largest US HIV cohort. In: AIDS 2020: 23rd International AIDS Conference Virtual, 2020.

Santiago-Rodriguez EI, Maiorana A, Peluso MJ, et al. Characterizing the COVID-19 illness experience to inform the study of post-acute sequelae and recovery. Int J Behav Med 2021: 1–14.

Tang ME, Gaufin T, Anson R, Zhu W, Mathews William C, Cachay ER. People with HIV have a higher risk of COVID-19 diagnosis but similar outcomes to the general population. HIV Medicine.

Chang JJ, Bruxvoort K, Chen LH, Akhavan B, Rodriguez J, Hechter RC. Brief report: COVID-19 testing, characteristics, and outcomes among people living with HIV in an integrated health system. JAIDS Journal of Acquired Immune Deficiency Syndromes 2021; 88(1).

Fazel S, Geddes JR, Kushel M. The health of homeless people in high-income countries: descriptive epidemiology, health consequences, and clinical and policy recommendations. Lancet. 2014;384(9953):1529–40.

PubMed  PubMed Central  Article  Google Scholar 

Aidala AA, Lee G, Abramson DM, Messeri P, Siegler A. Housing need, housing assistance, and connection to HIV medical care. AIDS Behav. 2007;11(6 Suppl):101–15.

PubMed  Article  Google Scholar 

Mosites E, Parker EM, Clarke KEN, et al. Assessment of SARS-CoV-2 infection prevalence in homeless shelters - four U.S. Cities, March 27-April 15, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(17):521–2.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Imbert E, Kinley PM, Scarborough A, et al. Coronavirus disease 2019 (COVID-19) outbreak in a San Francisco homeless shelter. Clin Infect Dis 2020.

Blanco JL, Ambrosioni J, Garcia F, et al. COVID-19 in patients with HIV: clinical case series. Lancet HIV. 2020;7(5):e314–6.

PubMed  PubMed Central  Article  Google Scholar 

Vizcarra P, Pérez-Elías MJ, Quereda C, et al. Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort. Lancet HIV. 2020;7(8):e554–64.

PubMed  PubMed Central  Article  Google Scholar 

Karmen-Tuohy S, Carlucci PM, Zervou FN, et al. Outcomes among HIV-positive patients hospitalized with COVID-19. J Acquir Immune Defic Syndr. 2020;85(1):6–10.

Childs K, Post FA, Norcross C, et al. Hospitalized patients with COVID-19 and HIV: a case series. Clin Infect Dis. 2020;71(8):2021–2.

Collins LF, Moran CA, Oliver NT, et al. Clinical characteristics, comorbidities and outcomes among persons with HIV hospitalized with coronavirus disease 2019 in Atlanta, GA. Aids. 2020;34(12):1789–94.

Meyerowitz EA, Kim AY, Ard KL, et al. Disproportionate burden of COVID-19 among racial minorities and those in congregate settings among a large cohort of people with HIV. Aids. 2020;34(12):1781–7.

Bhaskaran K, Rentsch CT, MacKenna B, et al. HIV infection and COVID-19 death: a population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platform. Lancet HIV. 2021;8(1):e24–32.

PubMed  Article  Google Scholar 

•• Bertagnolio S, Thwin SS, Silva R, et al. Clinical characteristics and prognostic factors in people living with HIV hospitalized with COVID-19: findings from the WHO Global Clinical Platform. IAS 2021; July 19, 2021. Abstract 2498. The WHO Global Clinical Platform presents data on the impact of HIV status on COVID-19 outcomes in a large, multi-country sample based on hospitalization data.

Yendewa GA, Perez JA, Schlick K, Tribout H, McComsey GA. Clinical features and outcomes of coronavirus disease 2019 among people with human immunodeficiency virus in the United States:

留言 (0)

沒有登入
gif